43063-0560 Ondansetron

Product NDC:

43063-0560

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: Ondansetron

Strength: 4.0

Unit: mg/1

Packages:

Code: 43063-0560-02

Description: 2 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-560-02)

Effective Date: April 4, 2016

Discontinued: Jan. 18, 2021

Code: 43063-0560-03

Description: 3 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-560-03)

Effective Date: April 4, 2016

Discontinued: Jan. 18, 2021

Code: 43063-0560-04

Description: 4 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-560-04)

Effective Date: April 4, 2016

Discontinued: Jan. 18, 2021

Code: 43063-0560-05

Description: 5 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-560-05)

Effective Date: Feb. 12, 2015

Discontinued: Jan. 18, 2021

Code: 43063-0560-06

Description: 6 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-560-06)

Effective Date: Feb. 12, 2015

Discontinued: Jan. 18, 2021

Code: 43063-0560-10

Description: 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-560-10)

Effective Date: Feb. 12, 2015

Discontinued: Jan. 18, 2021

Code: 43063-0560-20

Description: 20 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-560-20)

Effective Date: Feb. 12, 2015

Discontinued: Jan. 18, 2021

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

No Longer Used

CanMED and the Oncology Toolbox

CanMED: NDC